{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:02:27Z","timestamp":1780790547368,"version":"3.54.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"DOI":"10.7759\/cureus.110371","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:40:41Z","timestamp":1780789241000},"source":"Crossref","is-referenced-by-count":0,"title":["Narrative Review of Body-First Versus Brain-First Prodromal Neuropsychiatric Symptoms in Parkinson\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Saacha F","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshika","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shradha P","family":"Kakde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka  P","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashik Kumar","family":"Ashok Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Chepng'eno Koske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeby","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juviel Rev Reyes","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron Mathew","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somya","family":"Majji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Aswathappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri KR","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical E. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006, 5:235-45. 10.1016\/S1474-4422(06)70373-8","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma RB","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al.. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015, 30:1591-601. 10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.083113","article-title":"Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress","volume":"78","author":"Aarsland D","year":"2007","unstructured":"Aarsland D, Br\u00f8nnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2007, 78:36-42. 10.1136\/jnnp.2005.083113","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak H","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003, 24:197-211. 10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring Braak's hypothesis of Parkinson's disease","volume":"8","author":"Rietdijk CD","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD. Exploring Braak's hypothesis of Parkinson's disease. Front Neurol. 2017, 8:37. 10.3389\/fneur.2017.00037","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson's disease","volume":"139","author":"Sveinbjornsdottir S","year":"2016","unstructured":"Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. J Neurochem. 2016, 139:318-24. 10.1111\/jnc.13691","journal-title":"J Neurochem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-022-00934-6","article-title":"Parkinson's disease: a multisystem disorder","volume":"39","author":"Costa HN","year":"2023","unstructured":"Costa HN, Esteves AR, Empadinhas N, Cardoso SM. Parkinson's disease: a multisystem disorder. Neurosci Bull. 2023, 39:113-24. 10.1007\/s12264-022-00934-6","journal-title":"Neurosci Bull"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106101","article-title":"Brain-first vs. body-first Parkinson's disease: an update on recent evidence","volume":"122","author":"Horsager J","year":"2024","unstructured":"Horsager J, Borghammer P. Brain-first vs. body-first Parkinson's disease: an update on recent evidence. Parkinsonism Relat Disord. 2024, 122:106101. 10.1016\/j.parkreldis.2024.106101","journal-title":"Parkinsonism Relat Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg D","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, et al.. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015, 30:1600-11. 10.1002\/mds.26431","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad338","article-title":"Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET\/neuromelanin MRI study","volume":"147","author":"Laurencin C","year":"2024","unstructured":"Laurencin C, Lancelot S, Brosse S, et al.. Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET\/neuromelanin MRI study. Brain. 2024, 147:1377-88. 10.1093\/brain\/awad338","journal-title":"Brain"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx348","article-title":"Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study","volume":"141","author":"Sommerauer M","year":"2018","unstructured":"Sommerauer M, Fedorova TD, Hansen AK, et al.. Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study. Brain. 2018, 141:496-504. 10.1093\/brain\/awx348","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.152","article-title":"Advances in markers of prodromal Parkinson disease","volume":"12","author":"Postuma RB","year":"2016","unstructured":"Postuma RB, Berg D. Advances in markers of prodromal Parkinson disease. Nat Rev Neurol. 2016, 12:622-34. 10.1038\/nrneurol.2016.152","journal-title":"Nat Rev Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00622-7","article-title":"Neuropathology of incidental Lewy body & prodromal Parkinson's disease","volume":"18","author":"Koeglsperger T","year":"2023","unstructured":"Koeglsperger T, Rumpf SL, Schlie\u00dfer P, et al.. Neuropathology of incidental Lewy body & prodromal Parkinson's disease. Mol Neurodegener. 2023, 18:32. 10.1186\/s13024-023-00622-7","journal-title":"Mol Neurodegener"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy240","article-title":"Apathy in rapid eye movement sleep behaviour disorder is associated with serotonin depletion in the dorsal raphe nucleus","volume":"141","author":"Barber TR","year":"2018","unstructured":"Barber TR, Griffanti L, Muhammed K, et al.. Apathy in rapid eye movement sleep behaviour disorder is associated with serotonin depletion in the dorsal raphe nucleus. Brain. 2018, 141:2848-54. 10.1093\/brain\/awy240","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30058","article-title":"Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies","volume":"40","author":"\u017delezn\u00edkov\u00e1 \u017d","year":"2025","unstructured":"\u017delezn\u00edkov\u00e1 \u017d, Nov\u00e1kov\u00e1 L, Vojt\u00ed\u0161ek L, Brabenec L, Mitterov\u00e1 K, Mor\u00e1vkov\u00e1 I, Rektorov\u00e1 I. Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies. Mov Disord. 2025, 40:276-84. 10.1002\/mds.30058","journal-title":"Mov Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00377-X","article-title":"Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches","volume":"21","author":"Bohnen NI","year":"2022","unstructured":"Bohnen NI, Yarnall AJ, Weil RS, et al.. Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches. Lancet Neurol. 2022, 21:381-92. 10.1016\/S1474-4422(21)00377-X","journal-title":"Lancet Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel S","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB. Update of the MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2019, 34:1464-70. 10.1002\/mds.27802","journal-title":"Mov Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25857","article-title":"The neurobiological basis of cognitive impairment in Parkinson's disease","volume":"29","author":"Halliday GM","year":"2014","unstructured":"Halliday GM, Leverenz JB, Schneider JS, Adler CH. The neurobiological basis of cognitive impairment in Parkinson's disease. Mov Disord. 2014, 29:634-50. 10.1002\/mds.25857","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty RL","year":"2012","unstructured":"Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012, 8:329-39. 10.1038\/nrneurol.2012.80","journal-title":"Nat Rev Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2015.10.011","article-title":"Sleep in neurodegenerative diseases","volume":"11","author":"Iranzo A","year":"2016","unstructured":"Iranzo A. Sleep in neurodegenerative diseases. Sleep Med Clin. 2016, 11:1-18. 10.1016\/j.jsmc.2015.10.011","journal-title":"Sleep Med Clin"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00019-8","article-title":"Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment","volume":"14","author":"Pagonabarraga J","year":"2015","unstructured":"Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P. Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 2015, 14:518-31. 10.1016\/S1474-4422(15)00019-8","journal-title":"Lancet Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27461","article-title":"Fatigue in Parkinson's disease: a systematic review and meta-analysis","volume":"33","author":"Siciliano M","year":"2018","unstructured":"Siciliano M, Trojano L, Santangelo G, De Micco R, Tedeschi G, Tessitore A. Fatigue in Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2018, 33:1712-23. 10.1002\/mds.27461","journal-title":"Mov Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"F\u00e9nelon G","year":"2000","unstructured":"F\u00e9nelon G, Mahieux F, Huon R, Zi\u00e9gler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain. 2000, 123:733-45. 10.1093\/brain\/123.4.733","journal-title":"Brain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00809-0","article-title":"From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease","volume":"20","author":"Stefani A","year":"2025","unstructured":"Stefani A, Antelmi E, Arnaldi D, et al.. From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease. Mol Neurodegener. 2025, 20:19. 10.1186\/s13024-025-00809-0","journal-title":"Mol Neurodegener"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2309166","article-title":"Research progress on the relationship between Parkinson\u2019s disease and REM sleep behavior disorder","volume":"23","author":"Zhou Y","year":"2024","unstructured":"Zhou Y, Liu X, Xu B. Research progress on the relationship between Parkinson\u2019s disease and REM sleep behavior disorder. J Integr Neurosci. 2024, 23:166. 10.31083\/j.jin2309166","journal-title":"J Integr Neurosci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/26.5.507","article-title":"Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls","volume":"26","author":"Eisensehr I","year":"2003","unstructured":"Eisensehr I, Linke R, Tatsch K, et al.. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep. 2003, 26:507-12. 10.1093\/sleep\/26.5.507","journal-title":"Sleep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2015.08.025","article-title":"Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?","volume":"36","author":"Arnaldi D","year":"2015","unstructured":"Arnaldi D, De Carli F, Picco A, et al.. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?. Neurobiol Aging. 2015, 36:3300-5. 10.1016\/j.neurobiolaging.2015.08.025","journal-title":"Neurobiol Aging"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.5896","article-title":"Increased motor activity during REM sleep is linked with dopamine function in idiopathic REM sleep behavior disorder and Parkinson disease","volume":"12","author":"Zoetmulder M","year":"2016","unstructured":"Zoetmulder M, Nikolic M, Biernat H, Korbo L, Friberg L, Jennum P. Increased motor activity during REM sleep is linked with dopamine function in idiopathic REM sleep behavior disorder and Parkinson disease. J Clin Sleep Med. 2016, 12:895-903. 10.5664\/jcsm.5896","journal-title":"J Clin Sleep Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.25099","article-title":"Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease","volume":"100","author":"Valli M","year":"2022","unstructured":"Valli M, Uribe C, Mihaescu A, Strafella AP. Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease. J Neurosci Res. 2022, 100:1815-33. 10.1002\/jnr.25099","journal-title":"J Neurosci Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2147\/NSS.S328365","article-title":"Progressive pontine-medullary dysfunction leads to REM sleep behavior disorder symptoms in a chronic model of Parkinson\u2019s disease","volume":"13","author":"Du L","year":"2021","unstructured":"Du L, Xu L, Liang T, Wing YK, Ke Y, Yung WH. Progressive pontine-medullary dysfunction leads to REM sleep behavior disorder symptoms in a chronic model of Parkinson\u2019s disease. Nat Sci Sleep. 2021, 13:1723-36. 10.2147\/NSS.S328365","journal-title":"Nat Sci Sleep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26643","article-title":"Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis","volume":"31","author":"Broen MP","year":"2016","unstructured":"Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF. Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2016, 31:1125-33. 10.1002\/mds.26643","journal-title":"Mov Disord"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28404","article-title":"Neuroimaging of anxiety in Parkinson\u2019s disease: a systematic review","volume":"36","author":"Carey G","year":"2021","unstructured":"Carey G, G\u00f6rmezo\u011flu M, de Jong JJ, Hofman PA, Backes WH, Dujardin K, Leentjens AF. Neuroimaging of anxiety in Parkinson\u2019s disease: a systematic review. Mov Disord. 2021, 36:327-39. 10.1002\/mds.28404","journal-title":"Mov Disord"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107717","article-title":"Multidimensional mechanisms of anxiety and depression in Parkinson's disease: Integrating neuroimaging, neurocircuits, and molecular pathways","volume":"215","author":"Zhao J","year":"2025","unstructured":"Zhao J, Jia H, Ma P, Zhu D, Fang Y. Multidimensional mechanisms of anxiety and depression in Parkinson's disease: Integrating neuroimaging, neurocircuits, and molecular pathways. Pharmacol Res. 2025, 215:107717. 10.1016\/j.phrs.2025.107717","journal-title":"Pharmacol Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1055160","article-title":"Regional activity alterations in Parkinson's disease patients with anxiety disorders: A resting-state functional magnetic resonance imaging study","volume":"14","author":"Zhang P","year":"2022","unstructured":"Zhang P, Zhang Y, Luo Y, Wang L, Wang K. Regional activity alterations in Parkinson's disease patients with anxiety disorders: A resting-state functional magnetic resonance imaging study. Front Aging Neurosci. 2022, 14:1055160. 10.3389\/fnagi.2022.1055160","journal-title":"Front Aging Neurosci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00547-4","article-title":"Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies","volume":"9","author":"Lai TT","year":"2023","unstructured":"Lai TT, Gericke B, Feja M, Conoscenti M, Zelikowsky M, Richter F. Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies. NPJ Parkinsons Dis. 2023, 9:97. 10.1038\/s41531-023-00547-4","journal-title":"NPJ Parkinsons Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104749","article-title":"Prevalence and clinical aspects of depression in Parkinson's disease: a systematic review and meta\u2011analysis of 129 studies","volume":"141","author":"Cong S","year":"2022","unstructured":"Cong S, Xiang C, Zhang S, Zhang T, Wang H, Cong S. Prevalence and clinical aspects of depression in Parkinson's disease: a systematic review and meta\u2011analysis of 129 studies. Neurosci Biobehav Rev. 2022, 141:104749. 10.1016\/j.neubiorev.2022.104749","journal-title":"Neurosci Biobehav Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-022-00942-1","article-title":"Depression in patients with Parkinson\u2019s disease: current understanding of its neurobiology and implications for treatment","volume":"39","author":"Prange S","year":"2022","unstructured":"Prange S, Klinger H, Laurencin C, Danaila T, Thobois S. Depression in patients with Parkinson\u2019s disease: current understanding of its neurobiology and implications for treatment. Drugs Aging. 2022, 39:417-39. 10.1007\/s40266-022-00942-1","journal-title":"Drugs Aging"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1273855","article-title":"Unraveling the transcriptomic signatures of Parkinson's disease and major depression using single-cell and bulk data","volume":"15","author":"Christodoulou CC","year":"2023","unstructured":"Christodoulou CC, Onisiforou A, Zanos P, Papanicolaou EZ. Unraveling the transcriptomic signatures of Parkinson's disease and major depression using single-cell and bulk data. Front Aging Neurosci. 2023, 15:1273855. 10.3389\/fnagi.2023.1273855","journal-title":"Front Aging Neurosci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719807","article-title":"Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease","volume":"12","author":"Li Y","year":"2021","unstructured":"Li Y, Xia Y, Yin S, et al.. Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease. Front Immunol. 2021, 12:719807. 10.3389\/fimmu.2021.719807","journal-title":"Front Immunol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100035","article-title":"Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct \u03b1-synuclein assemblies","volume":"207","author":"Scheiblich H","year":"2021","unstructured":"Scheiblich H, Bousset L, Schwartz S, Griep A, Latz E, Melki R, Heneka MT. Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct \u03b1-synuclein assemblies. J Immunol. 2021, 207:2143-54. 10.4049\/jimmunol.2100035","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1159\/000381619","article-title":"Olfaction and aging: a mini-review","volume":"61","author":"Attems J","year":"2015","unstructured":"Attems J, Walker L, Jellinger KA. Olfaction and aging: a mini-review. Gerontology. 2015, 61:485-90. 10.1159\/000381619","journal-title":"Gerontology"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22229","article-title":"Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations","volume":"23","author":"Leentjens AF","year":"2008","unstructured":"Leentjens AF, Dujardin K, Marsh L, et al.. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008, 23:2004-14. 10.1002\/mds.22229","journal-title":"Mov Disord"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.4.2.134","article-title":"Reliability, validity, and clinical correlates of apathy in Parkinson's disease","volume":"4","author":"Starkstein SE","year":"1992","unstructured":"Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1992, 4:134-9. 10.1176\/jnp.4.2.134","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5882","article-title":"Distinguishing apathy from depression: a review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders","volume":"38","author":"Lanct\u00f4t KL","year":"2023","unstructured":"Lanct\u00f4t KL, Ismail Z, Bawa KK, Cummings JL, Husain M, Mortby ME, Robert P. Distinguishing apathy from depression: a review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders. Int J Geriatr Psychiatry. 2023, 38:e5882. 10.1002\/gps.5882","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2017.07.003","article-title":"The anatomy of apathy: a neurocognitive framework for amotivated behaviour","volume":"118","author":"Le Heron C","year":"2018","unstructured":"Le Heron C, Apps MA, Husain M. The anatomy of apathy: a neurocognitive framework for amotivated behaviour. Neuropsychologia. 2018, 118:54-67. 10.1016\/j.neuropsychologia.2017.07.003","journal-title":"Neuropsychologia"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.62347\/AICM8774","article-title":"PET, SPECT, and MRI imaging for evaluation of Parkinson's disease","volume":"14","author":"Gujral J","year":"2024","unstructured":"Gujral J, Gandhi OH, Singh SB, et al.. PET, SPECT, and MRI imaging for evaluation of Parkinson's disease. Am J Nucl Med Mol Imaging. 2024, 14:371-90. 10.62347\/AICM8774","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.12.024","article-title":"Reward processing dysfunction in ventral striatum and orbitofrontal cortex in Parkinson's disease","volume":"48","author":"du Plessis S","year":"2018","unstructured":"du Plessis S, Bossert M, Vink M, et al.. Reward processing dysfunction in ventral striatum and orbitofrontal cortex in Parkinson's disease. Parkinsonism Relat Disord. 2018, 48:82-8. 10.1016\/j.parkreldis.2017.12.024","journal-title":"Parkinsonism Relat Disord"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327762","article-title":"Disrupted reward processing in Parkinson's disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysis","volume":"93","author":"Costello H","year":"2022","unstructured":"Costello H, Berry AJ, Reeves S, Weil RS, Joyce EM, Howard R, Roiser JP. Disrupted reward processing in Parkinson's disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2022, 93:555-62. 10.1136\/jnnp-2021-327762","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0251-14.2014","article-title":"Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing","volume":"34","author":"Mart\u00ednez-Horta S","year":"2014","unstructured":"Mart\u00ednez-Horta S, Riba J, de Bobadilla RF, et al.. Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing. J Neurosci. 2014, 34:5918-26. 10.1523\/JNEUROSCI.0251-14.2014","journal-title":"J Neurosci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26208","article-title":"Apathy in Parkinson's disease: a systematic review and meta-analysis","volume":"30","author":"den Brok MG","year":"2015","unstructured":"den Brok MG, van Dalen JW, van Gool WA, Moll van Charante EP, de Bie RM, Richard E. Apathy in Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2015, 30:759-69. 10.1002\/mds.26208","journal-title":"Mov Disord"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082216","article-title":"Treatment of apathy in Parkinson\u2019s disease and implications for underlying pathophysiology","volume":"13","author":"Maher S","year":"2024","unstructured":"Maher S, Donlon E, Mullane G, Walsh R, Lynch T, Fearon C. Treatment of apathy in Parkinson\u2019s disease and implications for underlying pathophysiology. J Clin Med. 2024, 13:10.3390\/jcm13082216","journal-title":"J Clin Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland D","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021, 7:47. 10.1038\/s41572-021-00280-3","journal-title":"Nat Rev Dis Primers"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan I","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, et al.. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012, 27:349-56. 10.1002\/mds.24893","journal-title":"Mov Disord"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20974","article-title":"Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia","volume":"21","author":"Janvin CC","year":"2006","unstructured":"Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord. 2006, 21:1343-9. 10.1002\/mds.20974","journal-title":"Mov Disord"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2004.01.030","article-title":"Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies","volume":"22","author":"Nagano-Saito A","year":"2004","unstructured":"Nagano-Saito A, Kato T, Arahata Y, et al.. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage. 2004, 22:553-61. 10.1016\/j.neuroimage.2004.01.030","journal-title":"Neuroimage"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi M","year":"2011","unstructured":"Shi M, Bradner J, Hancock AM, et al.. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011, 69:570-80. 10.1002\/ana.22311","journal-title":"Ann Neurol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31829c5c86","article-title":"Evolution of mild cognitive impairment in Parkinson disease","volume":"81","author":"Broeders M","year":"2013","unstructured":"Broeders M, de Bie RM, Velseboer DC, Speelman JD, Muslimovic D, Schmand B. Evolution of mild cognitive impairment in Parkinson disease. Neurology. 2013, 81:346-52. 10.1212\/WNL.0b013e31829c5c86","journal-title":"Neurology"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre M","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, et al.. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007, 22:1689-707; quiz 1837. 10.1002\/mds.21507","journal-title":"Mov Disord"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23868","article-title":"Executive functions in Parkinson's disease: systematic review and meta-analysis","volume":"26","author":"Kudlicka A","year":"2011","unstructured":"Kudlicka A, Clare L, Hindle JV. Executive functions in Parkinson's disease: systematic review and meta-analysis. Mov Disord. 2011, 26:2305-15. 10.1002\/mds.23868","journal-title":"Mov Disord"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26511","article-title":"Parkinson's disease-related fatigue: a case definition and recommendations for clinical research","volume":"31","author":"Kluger BM","year":"2016","unstructured":"Kluger BM, Herlofson K, Chou KL, et al.. Parkinson's disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord. 2016, 31:625-31. 10.1002\/mds.26511","journal-title":"Mov Disord"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon V","year":"2009","unstructured":"Voon V, Fernagut PO, Wickens J, et al.. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol. 2009, 8:1140-9. 10.1016\/S1474-4422(09)70287-X","journal-title":"Lancet Neurol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00863-3","article-title":"Prodromal Parkinson's disease and subsequent risk of Parkinson's disease and mortality","volume":"11","author":"Chen X","year":"2025","unstructured":"Chen X, Li Y, Shen Y, Schwarzschild MA, Gao X. Prodromal Parkinson's disease and subsequent risk of Parkinson's disease and mortality. NPJ Parkinsons Dis. 2025, 11:14. 10.1038\/s41531-024-00863-3","journal-title":"NPJ Parkinsons Dis"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.7916\/D8N879HS","article-title":"REM sleep behavior disorder and prodromal neurodegeneration: where are we headed?","volume":"3","author":"Postuma RB","year":"2013","unstructured":"Postuma RB, Gagnon JF, Montplaisir JY. REM sleep behavior disorder and prodromal neurodegeneration: where are we headed?. Tremor Other Hyperkinet Mov (N Y). 2013, 3:10.7916\/D8N879HS","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acx091","article-title":"Cognitive and neuropsychiatric features of early Parkinson\u2019s disease","volume":"32","author":"Getz SJ","year":"2017","unstructured":"Getz SJ, Levin B. Cognitive and neuropsychiatric features of early Parkinson\u2019s disease. Arch Clin Neuropsychol. 2017, 32:769-85. 10.1093\/arclin\/acx091","journal-title":"Arch Clin Neuropsychol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2023.11.001","article-title":"A general clinical overview of the non-motor symptoms in Parkinson's disease: neuropsychiatric symptoms","volume":"174","author":"Batzu L","year":"2024","unstructured":"Batzu L, Podlewska A, Gibson L, Chaudhuri KR, Aarsland D. A general clinical overview of the non-motor symptoms in Parkinson's disease: neuropsychiatric symptoms. Int Rev Neurobiol. 2024, 174:59-97. 10.1016\/bs.irn.2023.11.001","journal-title":"Int Rev Neurobiol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001151","article-title":"Diagnosis and treatment of cognitive and neuropsychiatric symptoms in Parkinson disease and dementia with Lewy bodies","volume":"28","author":"Weintraub D","year":"2022","unstructured":"Weintraub D, Irwin D. Diagnosis and treatment of cognitive and neuropsychiatric symptoms in Parkinson disease and dementia with Lewy bodies. Continuum (Minneap Minn). 2022, 28:1314-32. 10.1212\/CON.0000000000001151","journal-title":"Continuum (Minneap Minn)"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01144-2","article-title":"Digital biomarkers for non-motor symptoms in Parkinson's disease: the state of the art","volume":"7","author":"Janssen Daalen JM","year":"2024","unstructured":"Janssen Daalen JM, van den Bergh R, Prins EM, et al.. Digital biomarkers for non-motor symptoms in Parkinson's disease: the state of the art. NPJ Digit Med. 2024, 7:186. 10.1038\/s41746-024-01144-2","journal-title":"NPJ Digit Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-02100327-x","article-title":"Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease","volume":"16","author":"Meles SK","unstructured":"Meles SK, Oertel WH, Leenders KL. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease. Mol Med. Sep. 16:2021-27. 10.1186\/s10020-02100327-x","journal-title":"Mol Med. Sep"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29921","article-title":"Smartphone voice calls provide early biomarkers of parkinsonism in rapid eye movement sleep behavior disorder","volume":"39","author":"Illner V","year":"2024","unstructured":"Illner V, Novotn\u00fd M, Kouba T, et al.. Smartphone voice calls provide early biomarkers of parkinsonism in rapid eye movement sleep behavior disorder. Mov Disord. 2024, 39:1752-62. 10.1002\/mds.29921","journal-title":"Mov Disord"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-0181910-4","article-title":"Diagnostic biomarkers for Parkinson's disease at a glance: where are we?","volume":"125","author":"Cova I","year":"2018","unstructured":"Cova I, Priori A. Diagnostic biomarkers for Parkinson's disease at a glance: where are we?. J Neural Transm (Vienna). 2018, 125:1417-32. 10.1007\/s00702-0181910-4","journal-title":"J Neural Transm (Vienna)"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-01902001-3","article-title":"Biomarkers of Parkinson's disease: 20 years later","volume":"126","author":"Yilmaz R","year":"2019","unstructured":"Yilmaz R, Hopfner F, van Eimeren T, Berg D. Biomarkers of Parkinson's disease: 20 years later. J Neural Transm (Vienna). 2019, 126:803-13. 10.1007\/s00702-01902001-3","journal-title":"J Neural Transm (Vienna)"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.321","article-title":"Preclinical biomarkers of Parkinson disease","volume":"68","author":"Wu Y","year":"2011","unstructured":"Wu Y, Le W, Jankovic J. Preclinical biomarkers of Parkinson disease. Arch Neurol. 2011, 68:22-30. 10.1001\/archneurol.2010.321","journal-title":"Arch Neurol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0607-4","article-title":"Advances in biomarker research in Parkinson's disease","volume":"16","author":"Mehta SH","year":"2016","unstructured":"Mehta SH, Adler CH. Advances in biomarker research in Parkinson's disease. Curr Neurol Neurosci Rep. 2016, 16:7. 10.1007\/s11910-015-0607-4","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108085","article-title":"New hopes for disease modification in Parkinson's Disease","volume":"171","author":"Poewe W","year":"2020","unstructured":"Poewe W, Seppi K, Marini K, Mahlknecht P. New hopes for disease modification in Parkinson's Disease. Neuropharmacology. 2020, 171:108085. 10.1016\/j.neuropharm.2020.108085","journal-title":"Neuropharmacology"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2014.11.010","article-title":"Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease","volume":"49","author":"Hirao K","year":"2015","unstructured":"Hirao K, Pontone GM, Smith GS. Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease. Neurosci Biobehav Rev. 2015, 49:157-70. 10.1016\/j.neubiorev.2014.11.010","journal-title":"Neurosci Biobehav Rev"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2018.12.005","article-title":"Cerebrospinal fluid biomarker for Parkinson's disease: an overview","volume":"97","author":"Maass F","year":"2019","unstructured":"Maass F, Schulz I, Lingor P, Mollenhauer B, B\u00e4hr M. Cerebrospinal fluid biomarker for Parkinson's disease: an overview. Mol Cell Neurosci. 2019, 97:60-6. 10.1016\/j.mcn.2018.12.005","journal-title":"Mol Cell Neurosci"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200897","article-title":"Statistical considerations in the design of clinical trials targeting prodromal Parkinson disease","volume":"99","author":"Macklin EA","year":"2022","unstructured":"Macklin EA, Coffey CS, Brumm MC, Seibyl JP. Statistical considerations in the design of clinical trials targeting prodromal Parkinson disease. Neurology. 2022, 99:68-75. 10.1212\/WNL.0000000000200897","journal-title":"Neurology"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa461","article-title":"Sequence of clinical and neurodegeneration events in Parkinson's disease progression","volume":"144","author":"Oxtoby NP","year":"2021","unstructured":"Oxtoby NP, Leyland LA, Aksman LM, et al.. Sequence of clinical and neurodegeneration events in Parkinson's disease progression. Brain. 2021, 144:975-88. 10.1093\/brain\/awaa461","journal-title":"Brain"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2020.07.011","article-title":"The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases","volume":"29","author":"Cummings J","year":"2021","unstructured":"Cummings J. The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases. Am J Geriatr Psychiatry. 2021, 29:375-83. 10.1016\/j.jagp.2020.07.011","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.10.007","article-title":"Neuropsychological impairment in prodromal Parkinson's disease","volume":"371","author":"Pausch C","year":"2016","unstructured":"Pausch C, Schomburg R, Wagenpfeil S, Wollenweber FA, Bayer C, Fassbender K, Behnke S. Neuropsychological impairment in prodromal Parkinson's disease. J Neurol Sci. 2016, 371:117-20. 10.1016\/j.jns.2016.10.007","journal-title":"J Neurol Sci"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-150685","article-title":"The concept of prodromal Parkinson\u2019s disease","volume":"5","author":"Mahlknecht P","year":"2015","unstructured":"Mahlknecht P, Seppi K, Poewe W. The concept of prodromal Parkinson\u2019s disease. J Parkinsons Dis. 2015, 5:681-97. 10.3233\/JPD-150685","journal-title":"J Parkinsons Dis"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3390\/biology9050103","article-title":"Clinical features of Parkinson\u2019s disease: the evolution of critical symptoms","volume":"9","author":"V\u00e1radi C","year":"2020","unstructured":"V\u00e1radi C. Clinical features of Parkinson\u2019s disease: the evolution of critical symptoms. Biology (Basel). 2020, 9:10.3390\/biology9050103","journal-title":"Biology (Basel)"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire: a new diagnostic instrument","volume":"22","author":"Stiasny-Kolster K","year":"2007","unstructured":"Stiasny-Kolster K, Mayer G, Sch\u00e4fer S, M\u00f6ller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire: a new diagnostic instrument. Movement Disorders. 2007, 22:2386-2393. 10.1002\/mds.21740","journal-title":"Movement Disorders"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1300\/J018v05n01_09","article-title":"Geriatric Depression Scale (GDS): recent evidence and development of a shorter version","volume":"5","author":"Sheikh JI","year":"1986","unstructured":"Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clinical Gerontologist. 1986, 5:165-173. 10.1300\/J018v05n01_09","journal-title":"Clinical Gerontologist"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery SA","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry. 1979, 134:382-389. 10.1192\/bjp.134.4.382","journal-title":"British Journal of Psychiatry"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105922","article-title":"From prodromal stages to clinical trials: the promise of digital speech biomarkers in Parkinson's disease","volume":"167","author":"Rusz J","year":"2024","unstructured":"Rusz J, Krack P, Tripoliti E. From prodromal stages to clinical trials: the promise of digital speech biomarkers in Parkinson's disease. Neurosci Biobehav Rev. 2024, 167:105922. 10.1016\/j.neubiorev.2024.105922","journal-title":"Neurosci Biobehav Rev"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-019-00433-1","article-title":"Biomarkers for Parkinson\u2019s disease: how good are they?","volume":"36","author":"Li T","year":"2020","unstructured":"Li T, Le W. Biomarkers for Parkinson\u2019s disease: how good are they?. Neurosci Bull. 2020, 36:183-94. 10.1007\/s12264-019-00433-1","journal-title":"Neurosci Bull"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/480959-narrative-review-of-body-first-versus-brain-first-prodromal-neuropsychiatric-symptoms-in-parkinsons-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:40:42Z","timestamp":1780789242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/480959-narrative-review-of-body-first-versus-brain-first-prodromal-neuropsychiatric-symptoms-in-parkinsons-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":87,"URL":"https:\/\/doi.org\/10.7759\/cureus.110371","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,6]]}}}